<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/6/225" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/6/225/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/6/225/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_225"><akn:num>225</akn:num><akn:heading>Reports, evaluations, and research regarding drug interdiction at and between ports of entry</akn:heading><akn:content><akn:p>§ 225. Reports, evaluations, and research regarding drug interdiction at and between ports of entry(a) Research on additional technologies to detect fentanylNot later than one year after December 23, 2022, the Secretary of Homeland Security, in consultation with the Attorney General, the Secretary of Health and Human Services, and the Director of the Office of National Drug Control Policy, shall research additional technological solutions to—(1) target and detect illicit fentanyl, fentanyl analogs, and precursor chemicals, including low-purity fentanyl, especially in counterfeit pressed tablets, and illicit pill press molds; and

(2) enhance detection of such counterfeit pressed tablets through nonintrusive, noninvasive, and other advanced screening technologies.


(b) Evaluation of current technologies and strategies in illicit drug interdiction and procurement decisions(1) In generalThe Secretary of Homeland Security, in consultation with the Attorney General, the Secretary of Health and Human Services, and the Director of the Office of National Drug Control Policy, shall establish a program to collect available data and develop metrics to measure how technologies and strategies used by the Department of Homeland Security, U.S. Customs and Border Protection, U.S. Immigration and Customs Enforcement, and other relevant Federal agencies have helped detect trafficked illicit fentanyl, fentanyl analogs, and precursor chemicals or deter illicit fentanyl, fentanyl analogs, and precursor chemicals from being trafficked into the United States at and between land, air, and sea ports of entry.


(2) ConsiderationsThe data and metrics program established pursuant to paragraph (1) may consider—(A) the rate of detection of illicit fentanyl, fentanyl analogs, and precursor chemicals at land, air, and sea ports of entry;

(B) investigations and intelligence sharing into the origins of illicit fentanyl, fentanyl analogs, and precursor chemicals within the United States; and

(C) </akn:p></akn:content><akn:subsection eId="subsec_225_a"><akn:num>(a)</akn:num><akn:heading>Research on additional technologies to detect fentanyl</akn:heading><akn:content><akn:p>(a) Research on additional technologies to detect fentanyl Not later than one year after December 23, 2022, the Secretary of Homeland Security, in consultation with the Attorney General, the Secretary of Health and Human Services, and the Director of the Office of National Drug Control Policy, shall research additional technological solutions to—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_225_b"><akn:num>(b)</akn:num><akn:heading>Evaluation of current technologies and strategies in illicit drug interdiction and procurement decisions</akn:heading><akn:content><akn:p>(b) Evaluation of current technologies and strategies in illicit drug interdiction and procurement decisions</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>